The Group is focused on improving outcomes for adult patients with leukemias or related hematologic malignancies (blood cancers). Members operate clinical trials, including large standard-practice changing phase III studies. The Group also develops robust survivorship studies, taking advantage of the large number of patients already included in phase III research.


Want to read in detail our scientific findings on specific tumour type?
Search through our comprehensive list of EORTC published articles to date.